MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/jth.14686

Медицинская библиотека · Journal of thrombosis and haemostasis : JTH · 2019

Von Willebrand factor and ADAMTS13 impact on the outcome of Staphylococcus aureus sepsis.

Peetermans Marijke, Meyers Severien, Liesenborghs Laurens, Vanhoorelbeke Karen, De Meyer Simon F, Vandenbriele Christophe, Lox Marleen, Hoylaerts Marc F, Martinod Kimberly, Jacquemin Marc, Vanassche Thomas, Verhamme Peter

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Previous clinical evidence correlates levels of von Willebrand factor (VWF) and its cleaving protease ADAMTS13 with outcome in septic patients. No previous studies addressed if VWF and ADAMTS13 affected the outcome of Staphylococcus aureus sepsis.

OBJECTIVES

We studied the role of VWF and ADAMTS13 in S. aureus sepsis both in patients and in mice.

METHODS

VWF levels and ADAMTS13 activity levels were measured in plasma samples from 89 S. aureus bacteremia patients by chemiluminescent assays and were correlated with clinical sepsis outcome parameters. In wild-type mice and mice deficient in VWF and ADAMTS13, we investigated the outcome of S. aureus sepsis and quantified bacterial clearance and organ microthrombi.

RESULTS

In patients with S. aureus bloodstream infections, high VWF levels and low ADAMTS13 activity levels correlated with disease severity and with parameters of inflammation and disseminated intravascular coagulation. In septic mice, VWF deficiency attenuated mortality, whereas ADAMTS13 deficiency increased mortality. Bacterial clearance was enhanced in VWF-deficient mice. The differences in mortality for the studied genotypes were associated with differential loads of organ microthrombi in both liver and kidneys.

CONCLUSIONS

In conclusion, this study reports the consistent relation of VWF, ADAMTS13 and their ratio to disease severity in patients and mice with S. aureus sepsis. Targeting VWF multimers and/or the relative ADAMTS13 deficiency that occurs in sepsis should be explored as a potential new therapeutic target in S. aureus endovascular infections.

Для цитирования: Peetermans Marijke, Meyers Severien, Liesenborghs Laurens, Vanhoorelbeke Karen, De Meyer Simon F, Vandenbriele Christophe, Lox Marleen, Hoylaerts Marc F, Martinod Kimberly, Jacquemin Marc, Vanassche Thomas, Verhamme Peter. Von Willebrand factor and ADAMTS13 impact on the outcome of Staphylococcus aureus sepsis.. Journal of thrombosis and haemostasis : JTH. 2019. DOI: 10.1111/jth.14686.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.